Congress Passes FY 2026 Funding, Securing Cancer Surveillance Programs

Congress Passes FY 2026 Funding, Securing Cancer Surveillance Programs February 3, 2026

ALEXANDRIA, VA, UNITED STATES, July 22, 2026 /EINPresswire.com/ -- The U.S. House of Representatives today approved the Fiscal Year (FY) 2026 appropriations package, finalizing funding for critical health programs including cancer surveillance. The package, which passed the Senate on Friday, January 30, 2026, provides $53.4 million for the CDC's National Program of Cancer Registries (NPCR) and increases funding for the National Cancer Institute by $150 million over FY 2025 levels.

"This is a tremendous victory for cancer surveillance and the patients who depend on accurate, comprehensive cancer data," said Lori Swain, Executive Director of the National Cancer Registrars Association (NCRA). "Congress has sent a clear, bipartisan message that cancer surveillance is essential to our nation's public health infrastructure."

The approval marks the successful conclusion of months of advocacy efforts by NCRA and its partners. When the Administration's FY 2026 budget proposal called for eliminating funding for the NPCR and cutting NIH cancer programs by 40%, NCRA mobilized hundreds of volunteers to educate members of Congress about the vital importance of cancer registries to patient care, research, and public health.

While the $53.4 million for NPCR represents flat funding from FY 2025, it is a remarkable achievement given the Administration's proposal to eliminate the program entirely. The NCI increase of $150 million will support the Surveillance, Epidemiology and End Results Program (SEER) and other critical cancer research initiatives.

"Cancer registrars across the country can continue their essential work collecting the data that drives cancer research, guides treatment decisions, and helps save lives," Swain added. "We are grateful to the Members of Congress who recognized the importance of this work and fought to preserve these programs."

Lauren Martella
National Cancer Registry Association
+ +1 703-299-6640
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.